S. Distasio

Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer

Yung-chi Cheng, J. Leffert, B. Burtness, 2000, Cancer Chemotherapy and Pharmacology.

A results-driven risk management program: one surgical group's success story.

Kevin Kelly, R. Orlando, S. Distasio, 2013, Physician executive.

Differential effects of the organochlorine pesticide DDT and its metabolite p,p'-DDE on p-glycoprotein activity and expression.

C. Cardozo, M. Wolff, A. Shabbir, 2005, Toxicology and applied pharmacology.

Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies.

A. Sartorelli, E. Zuhowski, M. Egorin, 2000, Cancer journal.

Cdc37 has distinct roles in protein kinase quality control that protect nascent chains from degradation and promote posttranslational maturation

Nadinath B. Nillegoda, J. Brodsky, A. K. Mandal, 2007, The Journal of cell biology.

Phase II Trial of 9-Aminocamptothecin as a 72-h Infusion in Cutaneous T-Cell Lymphoma

S. Arbuck, A. Argiris, T. Kuzel, 2001, Investigational New Drugs.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

L. Wilson, D. Ross, D. Zelterman, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I Study of Perillyl Alcohol in Patients with Refractory Malignancies

A. Sartorelli, B. Burtness, J. Murren, 2002, Cancer biology & therapy.

Integrating yoga into cancer care.

S. Distasio, 2008, Clinical journal of oncology nursing.

Cdc37 has distinct roles in protein kinase quality control that protect nascent chains from degradation and promote posttranslational maturation

Nadinath B. Nillegoda, J. Brodsky, A. K. Mandal, 2007, The Journal of cell biology.